• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Rosetta Genomics, Ltd. (ROSG)

    -NasdaqCM
    2.30 Down 0.05(2.13%) 4:00PM EST
    Add to Portfolio
    Prev Close:2.35
    Open:2.37
    Bid:2.26 x 2500
    Ask:3.16 x 300
    1y Target Est:8.00
    Beta:-11.82
    Earnings Date:Dec 28 - Jan 1 (Est.)
    Day's Range:2.30 - 2.37
    52wk Range:2.07 - 6.69
    Volume:50,195
    Avg Vol (3m):68,464
    Market Cap:25.83M
    P/E (ttm):N/A
    EPS (ttm):-1.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ROSG

    Comparison

    Symbol% ChgMkt Cap
    ROSGDown 2.13%25.83M
    ALNYUp 1.33%7.75B
    ISISUp 9.30%7.69B
    MRKUp 1.02%169.86B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):34.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :-1.33
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.07

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rosetta Genomics Ltd. develops and commercializes microRNAs based diagnostic tests and therapeutics. MicroRNAs are a group of genes that are produced using instructions encoded in DNA. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback